High Tower Advisors, LLC Allogene Therapeutics, Inc. Transaction History
High Tower Advisors, LLC
- $64.2 Billion
- Q2 2024
A detailed history of High Tower Advisors, LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 30,556 shares of ALLO stock, worth $98,390. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,556
Previous 30,556
-0.0%
Holding current value
$98,390
Previous $136,000
47.79%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding ALLO
# of Institutions
172Shares Held
130MCall Options Held
94.3KPut Options Held
112K-
Tpg Gp A, LLC Fort Worth, TX18.7MShares$60.3 Million1.08% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$53 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.2MShares$26.4 Million0.0% of portfolio
-
State Street Corp Boston, MA7.67MShares$24.7 Million0.0% of portfolio
-
Capital World Investors Los Angeles, CA6.9MShares$22.2 Million0.0% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $463M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...